Research output per year
Research output per year
Search results
-
2016
ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.
Weir, J.-A., Gilliland, P., Fuchs, M.-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research InstituteResearch output: Chapter in Book/Report/Conference proceeding › Conference contribution
-
Validation of a MEK/MET-specific NGS panel for early phase trial interrogation
Maxwell, P., del favero, J., Fuchs, M.-A., Tabernero, J., Maughan, T., Middleton, M., Adams, R., Rolfo, C., Hennessy, B. T., Laurent=puig, P., Bardelli, A., Andre, T., Popovici, V., Johnston, P., Wilson, R., Lawler, M., Van Schaeybroeck, S. & Salto-Tellez, M., 01 May 2016, Validation of a MEK/MET-specific NGS panel for early phase trial interrogation . Proceedings: AACR Annual Meeting 2016; April 16-20 New Orleans, Vol. abstract 1396.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution